Drugs / XH-30002
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05927844 | Jun 2023 → Jun 2025 | esophageal squamous cell carcinoma | Fujian Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XH-30002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05927844 ↗ |